Featured Research

from universities, journals, and other organizations

Estrogen Found To Increase Growth Of The Most Common Childhood Brain Tumor

Date:
February 19, 2009
Source:
University of Cincinnati
Summary:
Researchers have discovered that estrogen receptors are present in medulloblastoma -- the most common type of pediatric brain tumor -- leading them to believe that anti-estrogen drug treatments may be beneficial in limiting tumor progression and improving patients' overall outcome.

Scott Belcher, PhD.
Credit: Image courtesy of University of Cincinnati

University of Cincinnati researchers have discovered that estrogen receptors are present in medulloblastoma—the most common type of pediatric brain tumor—leadingthem to believe that anti-estrogen drug treatments may be beneficial in limiting tumor progression and improving patients’ overall outcome.

This research is being published in the March 2009 edition of Endocrinology.

In estrogen-responsive cancers—such as breast cancer—estrogen receptors act to increase tumor growth and progression. Estrogen receptors are also the most important drug targets for the treatment of breast cancer.

“Current therapies for medulloblastoma involve cranial surgery, chemotherapy and radiation,” says Scott Belcher, PhD, principal investigator of the study. “This discovery suggests that we may be able to use anti-hormone or estrogen drug therapies—like those used to treat breast cancers—to limit progression of these childhood brain tumors and to decrease the adverse side-effects of radiation treatment.”

Medulloblastoma, or MD, is a highly malignant brain tumor, most commonly diagnosed in children.

Patients with MD typically have a five-year survival rate between 50 and 70 percent, and survivors who endure current, more aggressive treatments face an increased risk for chronic illnesses such as diabetes or cardiovascular disease later in life.

Belcher, an associate professor in the department of pharmacology and cell biophysics at UC, and his team examined tumor tissue from 22 patients between the ages of 6 months and 18 years.

They found evidence of estrogen receptors, particularly estrogen receptor beta, in the cancerous cells of every tumor analyzed.

“MD manifests when specific neuron precursors in the brain fail to stop normally differentiating into mature neurons,” Belcher says. “Our previous studies showed that estrogen receptors are regulated during differentiation of these neuronal precursors. MD growth and tumor cell formation can be blocked by inhibiting the activity of these receptors.”

Belcher said these resultsdemonstrate the importance of “bench to bedside” discoveries.

“We started in tumor cells and then moved to animal models of MD and found that we could stop the growth of tumors using anti-estrogen therapies,” he says. “We’ve been able to identify these receptors in humans. We are now hoping that our basic developmental biology findings can take the final step by stopping the growth of these tumors in humans.”

“We believe that development of rational anti-estrogen drug therapies for this highly malignant cancer is a possibility and could improve the lives of many children and adult survivors,” he continues.

This study was funded by the National Institute of Environmental Health Sciences and a Translation Research grant from Cincinnati Children’s Hospital Medical Center.


Story Source:

The above story is based on materials provided by University of Cincinnati. Note: Materials may be edited for content and length.


Cite This Page:

University of Cincinnati. "Estrogen Found To Increase Growth Of The Most Common Childhood Brain Tumor." ScienceDaily. ScienceDaily, 19 February 2009. <www.sciencedaily.com/releases/2009/02/090217112130.htm>.
University of Cincinnati. (2009, February 19). Estrogen Found To Increase Growth Of The Most Common Childhood Brain Tumor. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/2009/02/090217112130.htm
University of Cincinnati. "Estrogen Found To Increase Growth Of The Most Common Childhood Brain Tumor." ScienceDaily. www.sciencedaily.com/releases/2009/02/090217112130.htm (accessed September 19, 2014).

Share This



More Health & Medicine News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com
What HealthKit Bug Means For Your iOS Fitness Apps

What HealthKit Bug Means For Your iOS Fitness Apps

Newsy (Sep. 18, 2014) Apple has delayed the launch of the HealthKit app platform, citing a bug. Video provided by Newsy
Powered by NewsLook.com
U.S. Food Makers Surpass Calorie-Cutting Pledge

U.S. Food Makers Surpass Calorie-Cutting Pledge

Newsy (Sep. 18, 2014) Sixteen large food and beverage companies in the United States that committed to cut calories in their products far surpassed their target. Video provided by Newsy
Powered by NewsLook.com
Residents Vaccinated as Haiti Fights Cholera Epidemic

Residents Vaccinated as Haiti Fights Cholera Epidemic

AFP (Sep. 18, 2014) Haitians receive the second dose of the vaccine against cholera as part of the UN's vaccination campaign. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins